Literature DB >> 24965263

The Danish Civil Registration System as a tool in epidemiology.

Morten Schmidt1, Lars Pedersen, Henrik Toft Sørensen.   

Abstract

The methodological advances in epidemiology have facilitated the use of the Danish Civil Registration System (CRS) in ways not previously described systematically. We reviewed the CRS and its use as a research tool in epidemiology. We obtained information from the Danish Law on Civil Registration and the Central Office of Civil Registration, and used existing literature to provide illustrative examples of its use. The CRS is an administrative register established on April 2, 1968. It contains individual-level information on all persons residing in Denmark (and Greenland as of May 1, 1972). By January 2014, the CRS had cumulatively registered 9.5 million individuals and more than 400 million person-years of follow-up. A unique ten-digit Civil Personal Register number assigned to all persons in the CRS allows for technically easy, cost-effective, and unambiguous individual-level record linkage of Danish registers. Daily updated information on migration and vital status allows for nationwide cohort studies with virtually complete long-term follow-up on emigration and death. The CRS facilitates sampling of general population comparison cohorts, controls in case-control studies, family cohorts, and target groups in population surveys. The data in the CRS are virtually complete, have high accuracy, and can be retrieved for research purposes while protecting the anonymity of Danish residents. In conclusion, the CRS is a key tool for epidemiological research in Denmark.

Entities:  

Mesh:

Year:  2014        PMID: 24965263     DOI: 10.1007/s10654-014-9930-3

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  30 in total

1.  The use of weights to account for non-response and drop-out.

Authors:  Michael Höfler; Hildegard Pfister; Roselind Lieb; Hans-Ulrich Wittchen
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2005-04       Impact factor: 4.328

2.  Lifestyle profile among statin users.

Authors:  Reimar Wernich Thomsen; Rikke Beck Nielsen; Mette Nørgaard; Henriette Thisted Horsdal; Til Stürmer; Finn Breinholt Larsen; Henrik Toft Sørensen
Journal:  Epidemiology       Date:  2013-07       Impact factor: 4.822

Review 3.  The Nordic countries as a cohort for pharmacoepidemiological research.

Authors:  Kari Furu; Björn Wettermark; Morten Andersen; Jaana E Martikainen; Anna Birna Almarsdottir; Henrik Toft Sørensen
Journal:  Basic Clin Pharmacol Toxicol       Date:  2009-12-04       Impact factor: 4.080

4.  Glucocorticoid use and risk of atrial fibrillation or flutter: a population-based, case-control study.

Authors:  Christian Fynbo Christiansen; Steffen Christensen; Frank Mehnert; Steven R Cummings; Roland D Chapurlat; Henrik Toft Sørensen
Journal:  Arch Intern Med       Date:  2009-10-12

5.  The Danish Health Examination Survey 2007-2008 (DANHES 2007-2008).

Authors:  Louise Eriksen; Morten Grønbæk; Jørn Wulff Helge; Janne Schurmann Tolstrup; Tine Curtis
Journal:  Scand J Public Health       Date:  2011-01-21       Impact factor: 3.021

6.  Randomised placebo controlled multicentre trial to assess short term clarithromycin for patients with stable coronary heart disease: CLARICOR trial.

Authors:  Christian M Jespersen; Bodil Als-Nielsen; Morten Damgaard; Jørgen Fischer Hansen; Stig Hansen; Olav H Helø; Per Hildebrandt; Jørgen Hilden; Gorm B Jensen; Jens Kastrup; Hans Jørn Kolmos; Erik Kjøller; Inga Lind; Henrik Nielsen; Lars Petersen; Christian Gluud
Journal:  BMJ       Date:  2005-12-08

7.  Patients enrolled in coronary intervention trials are not representative of patients in clinical practice: results from the Euro Heart Survey on Coronary Revascularization.

Authors:  Marjo Hordijk-Trion; Mattie Lenzen; William Wijns; Peter de Jaegere; Maarten L Simoons; Wilma J M Scholte op Reimer; Michel E Bertrand; Nestor Mercado; Eric Boersma
Journal:  Eur Heart J       Date:  2006-01-19       Impact factor: 29.983

8.  Non-steroidal anti-inflammatory drug use and risk of atrial fibrillation or flutter: population based case-control study.

Authors:  Morten Schmidt; Christian F Christiansen; Frank Mehnert; Kenneth J Rothman; Henrik Toft Sørensen
Journal:  BMJ       Date:  2011-07-04

9.  The Danish National Health Survey 2010. Study design and respondent characteristics.

Authors:  Anne Illemann Christensen; Ola Ekholm; Charlotte Glümer; Anne Helms Andreasen; Michael Falk Hvidberg; Peter Lund Kristensen; Finn Breinholt Larsen; Britta Ortiz; Knud Juel
Journal:  Scand J Public Health       Date:  2012-06       Impact factor: 3.021

10.  Regional administrative health registries as a resource in clinical epidemiologyA study of options, strengths, limitations and data quality provided with examples of use.

Authors:  H T Sørensen
Journal:  Int J Risk Saf Med       Date:  1997
View more
  780 in total

1.  The Rotterdam Study: 2016 objectives and design update.

Authors:  Albert Hofman; Guy G O Brusselle; Sarwa Darwish Murad; Cornelia M van Duijn; Oscar H Franco; André Goedegebure; M Arfan Ikram; Caroline C W Klaver; Tamar E C Nijsten; Robin P Peeters; Bruno H Ch Stricker; Henning W Tiemeier; André G Uitterlinden; Meike W Vernooij
Journal:  Eur J Epidemiol       Date:  2015-09-19       Impact factor: 8.082

2.  Adjustment disorder and risk of Parkinson's disease.

Authors:  E Svensson; D K Farkas; J L Gradus; T L Lash; H T Sørensen
Journal:  Eur J Neurol       Date:  2016-01-12       Impact factor: 6.089

3.  A Single Positive Tissue Culture Increases the Risk of Rerevision of Clinically Aseptic THA: A National Register Study.

Authors:  Nikolaj R Milandt; Per H Gundtoft; Søren Overgaard
Journal:  Clin Orthop Relat Res       Date:  2019-06       Impact factor: 4.176

4.  Health Anxiety in Preadolescence--Associated Health Problems, Healthcare Expenditure, and Continuity in Childhood.

Authors:  Charlotte Ulrikka Rask; Anja Munkholm; Lars Clemmensen; Martin K Rimvall; Eva Ørnbøl; Pia Jeppesen; Anne Mette Skovgaard
Journal:  J Abnorm Child Psychol       Date:  2016-05

5.  Predictive pharmacogenetic biomarkers for breast cancer recurrence prevention by simvastatin.

Authors:  Thomas P Ahern; Per Damkier; Søren Feddersen; Anders Kjærsgaard; Timothy L Lash; Stephen Hamilton-Dutoit; Cathrine Bredal Lythjohan; Bent Ejlertsen; Peer M Christiansen; Deirdre P Cronin-Fenton
Journal:  Acta Oncol       Date:  2020-04-30       Impact factor: 4.089

6.  Pregnancy complications and subsequent breast cancer risk in the mother: a Nordic population-based case-control study.

Authors:  Rebecca Troisi; Anne Gulbech Ording; Tom Grotmol; Ingrid Glimelius; Anders Engeland; Mika Gissler; Britton Trabert; Anders Ekbom; Laura Madanat-Harjuoja; Henrik Toft Sørensen; Steinar Tretli; Tone Bjørge
Journal:  Int J Cancer       Date:  2018-08-10       Impact factor: 7.396

7.  Treatment and survival of glioblastoma patients in Denmark: The Danish Neuro-Oncology Registry 2009-2014.

Authors:  Steinbjørn Hansen; Birthe Krogh Rasmussen; René Johannes Laursen; Michael Kosteljanetz; Henrik Schultz; Bente Mertz Nørgård; Rikke Guldberg; Kim Oren Gradel
Journal:  J Neurooncol       Date:  2018-05-12       Impact factor: 4.130

8.  Association of Donor Age and Sex With Survival of Patients Receiving Transfusions.

Authors:  Gustaf Edgren; Henrik Ullum; Klaus Rostgaard; Christian Erikstrup; Ulrik Sartipy; Martin J Holzmann; Olof Nyrén; Henrik Hjalgrim
Journal:  JAMA Intern Med       Date:  2017-06-01       Impact factor: 21.873

9.  Vascular comorbidities in multiple sclerosis: a nationwide study from Denmark.

Authors:  Anja Thormann; Melinda Magyari; Nils Koch-Henriksen; Bjarne Laursen; Per Soelberg Sørensen
Journal:  J Neurol       Date:  2016-10-03       Impact factor: 4.849

10.  How to Identify Common Variable Immunodeficiency Patients Earlier: General Practice Patterns.

Authors:  Frederik V Ilkjær; Line D Rasmussen; Raquel Martin-Iguacel; Lena Westh; Terese L Katzenstein; Ann-Brit E Hansen; Thyge L Nielsen; Carsten S Larsen; Isik S Johansen
Journal:  J Clin Immunol       Date:  2019-08-01       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.